ZNF584 Inhibitors
Chemical inhibitors of ZNF584 include a variety of compounds that target different cellular pathways, each with a unique mechanism to inhibit the function of this protein. Palbociclib, a CDK4/6 inhibitor, prevents the phosphorylation of proteins that are crucial for the DNA-binding activity of ZNF584, thus directly interfering with its ability to regulate gene expression. Trichostatin A, an HDAC inhibitor, alters the acetylation status of histones surrounding the DNA, which can change the accessibility of the DNA binding sites for ZNF584, thereby inhibiting its function. This is complemented by the action of MG-132, a proteasome inhibitor, which can stabilize regulatory proteins that repress the activity of ZNF584 by preventing their degradation.
Further inhibition is achieved through the use of LY294002 and Wortmannin, both PI3K inhibitors, which disrupt the PI3K/AKT pathway that is potentially involved in post-translational modifications of proteins that associate with ZNF584. Rapamycin, an mTOR inhibitor, contributes to this inhibition by disturbing downstream signaling pathways that influence protein synthesis and degradation, which can indirectly inhibit ZNF584. Staurosporine broadly targets kinases that may phosphorylate proteins interacting with ZNF584, hence impacting its function. U0126 and SB203580, inhibitors of MEK and p38 MAPK, respectively, prevent the activation of pathways that could lead to the phosphorylation of ZNF584-associated proteins, while SP600125, a JNK inhibitor, blocks the phosphorylation of substrates that may modify ZNF584's activity. Y-27632, a ROCK inhibitor, disrupts cellular mechanics, which can influence ZNF584's localization and function. Lastly, Alsterpaullone, another cyclin-dependent kinase inhibitor, joins the array of inhibitors by also preventing the phosphorylation of proteins essential for ZNF584's activity, thereby directly inhibiting the protein's functional capabilities.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib is a CDK4/6 inhibitor that could inhibit ZNF584 by preventing the phosphorylation of proteins that are necessary for ZNF584 DNA-binding activity, since CDKs are often involved in cell cycle regulation and could phosphorylate proteins that interact with ZNF584. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase (HDAC) inhibitor that can inhibit ZNF584 by altering the acetylation status of histones, which potentially changes the chromatin structure and impacts the DNA-binding ability of ZNF584. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor that can inhibit ZNF584 by preventing the degradation of regulatory proteins that inhibit ZNF584 or its binding partners, thus maintaining a repressive environment for its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can inhibit ZNF584 by blocking the PI3K/AKT pathway, potentially leading to a reduction in post-translational modifications of proteins that interact with or regulate ZNF584. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can inhibit ZNF584 by disrupting downstream signaling pathways, which may lead to altered protein synthesis and degradation affecting proteins that regulate ZNF584 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor that can inhibit ZNF584 by broadly targeting kinases involved in phosphorylating proteins that interact with ZNF584, thus impacting its function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that can inhibit ZNF584 by preventing the activation of MAPK/ERK pathway, which could be responsible for the phosphorylation of proteins that associate with ZNF584, influencing its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that can inhibit ZNF584 by blocking the p38 MAPK pathway, potentially affecting the phosphorylation and activity of transcription factors or co-regulators of ZNF584. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor similar to LY294002 that can inhibit ZNF584 by impeding the PI3K/AKT pathway and potentially altering the phosphorylation state of proteins that regulate ZNF584. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that can inhibit ZNF584 by preventing the JNK signaling pathway from phosphorylating substrates that could modify ZNF584 activity or its interaction with DNA. | ||||||